Last updated: 2026-10-10 12:53:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Vivani Medical, Inc. (VANI) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.25, with a market capitalization of $110.95M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.92 to $1.92. This page covers its latest market performance, valuation, price trends and company information.
$110.95M | |
$1.22 | |
$7.80 | |
$0.75 | |
$1.23 | |
97.27K | |
207.52K | |
-- | |
$1.92 | |
$0.92 | |
-- | |
-- |
Vivani Medical, Inc. (VANI) last closed at $1.23 as of 2026-10-09 23:31:00, unchanged from the previous close of $1.23.
During the latest regular trading session, VANI traded between $0.75 and $7.80, with a volume of 97.27K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Vivani Medical, Inc. (VANI) moved from $1.22 to $1.25, representing a gain of 2.05% ($0.03).
The stock traded between $1.19 and $1.34 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 140.50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 32.3%
VANI is currently trading at $1.25, placing it 32.3% of the way from its 52-week low of $0.92 to its 52-week high of $1.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 36 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Vivani Medical, Inc. (VANI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.